{
    "relation": [
        [
            "Time/Date",
            "11:15 26-Sep-2014",
            "16:27 16-Sep-2014",
            "07:00 16-Sep-2014",
            "16:30 10-Sep-2014",
            "16:00 01-Sep-2014",
            "07:00 19-Aug-2014",
            "07:00 19-Aug-2014",
            "07:00 14-Aug-2014",
            "07:00 13-Aug-2014",
            "13:00 04-Aug-2014"
        ],
        [
            "Code",
            "AZN",
            "AZN",
            "AZN",
            "AZN",
            "AZN",
            "AZN",
            "AZN",
            "AZN",
            "AZN",
            "AZN"
        ],
        [
            "Headline",
            "Positive CHMP Opinion for MOVENTIG (naloxegol)",
            "FDA Approves MOVANTIK (naloxegol) Tablets",
            "AZ AND LILLY ALLIANCE TO DEVELOP BACE INHIBITOR",
            "Director/PDMR Shareholding",
            "Total Voting Rights",
            "US DOJ Closes Investigation into Plato",
            "CAZ-AVI PHASE III RESULTS",
            "TRALOKINUMAB PHASE III START IN SEVERE ASTHMA",
            "PHASE III RESULTS LESINURAD COMBINATION THERAPY",
            "Director/PDMR Shareholding"
        ],
        [
            "Source",
            "RNS",
            "RNS",
            "RNS",
            "RNS",
            "RNS",
            "RNS",
            "RNS",
            "RNS",
            "RNS",
            "RNS"
        ],
        [
            "Impact",
            "-1.81%",
            "-0.37%",
            "-0.37%",
            "-0.53%",
            "+1.56%",
            "+5.19%",
            "+5.19%",
            "+1.18%",
            "-0.13%",
            "-2.43%"
        ]
    ],
    "pageTitle": "ASTRAZENECA PLC ORD SHS $0.25 - London Stock Exchange",
    "title": "",
    "url": "http://www.londonstockexchange.com/exchange/prices-and-markets/stocks/exchange-insight/news-analysis.html?fourWayKey=GB0009895292GBGBXSET0&page=5",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 0,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042991076.30/warc/CC-MAIN-20150728002311-00242-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 557357035,
    "recordOffset": 557334025,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Previous | 1 | 2 | 3 | 4 | 5 | \u00a0Page 5 of 5 News News analysis Technical analysis Fundamentals Prices and trades Interactive chart Summary AZN ASTRAZENECA PLC ORD SHS $0.25 } image.src = '/media/img/void.gif'; image.onerror = null; function onErrorImage(image) { Follow @LSEplc ASTRAZENECA Stocks Prices\u00a0& markets Home page",
    "textAfterTable": "\u00a0Page 5 of 5 Previous | 1 | 2 | 3 | 4 | 5 | Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where: x = instrument's 7 closing prices after the news has been released y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security\u2019s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank \u201c - \u201c next to the line indicating the RNS issue.",
    "hasKeyColumn": true,
    "keyColumnIndex": 2,
    "headerRowIndex": 0
}